FDA advisory panel recommends Moderna booster for many adults

The vote isn't binding, but the FDA is expected to accept the recommendation.

April 15, 2025 · 1 min · 90 words · Richard Guzman

Table of Contents

These are thesame groups that became eligible for a Pfizer boosterlast month.

See also

TheCOVID-19 vaccines are highly effectivein preventing hospitalization and death.

Those who are unvaccinated have accounted fornearly all the hospitalizations and deaths– over 97% as of July.

The vote by the FDA panel isn’t binding, but the agency will likely accept the recommendation.

The FDAapproved the Pfizer booster shotless than a week after an advisory panel made its recommendation.

The panel is meeting again Friday to discuss a booster dose for the Johnson & Johnson COVID-19 vaccine.